(Q24542426)

6 July 2017

title

Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease (English)

1 reference

6 July 2017

1 reference

chronic liver disease

0 references

author name string

Parker G

series ordinal

1

1 reference

6 July 2017

Roberts CJ

series ordinal

2

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 September 1983

1 reference

British Journal of Clinical Pharmacology

6 July 2017

published in

1 reference

6 July 2017

volume

16

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

259-265

1 reference

Hepatic disease and drug pharmacokinetics

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Psychomotor function and psychoactive drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

A dose-response study in situational insomnia with zopiclone, a new tranquilizer.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effects of cirrhosis and ageing on the elimination and bioavailability of ranitidine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Metabolism of amylobarbitone in patients with chronic liver disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Intravenous administration of diazepam in patients with chronic liver disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Hepatic First-pass Metabolism in Liver Disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Protein Binding and Kinetics of Drugs in Liver Diseases

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effects of aging and liver disease on disposition of lorazepam

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Medium chain triglycerides and hepatic encephalopathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Determinants of serum antipyrine half-lives in patients with liver disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effect of portacaval shunt on the disposition of drugs with and without first-pass effect

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Normal disposition of oxazepam in acute viral hepatitis and cirrhosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium).

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1428012

Effects of Chlorpromazine in Patients with Hepatic Disease

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1983.TB02159.X

Decreased first-pass metabolism of labetalol in chronic liver disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6626417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The E.E.G. in hepatic encephalopathy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6626417

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1983.TB02159.X

1 reference

6 July 2017

1 reference

6 July 2017

1 reference